Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
oxaliplatin, Quantity: 200 mg
Medis Pharma Pty Ltd
Oxaliplatin
Injection, concentrated
Excipient Ingredients: lactose monohydrate; water for injections
Intravenous Infusion
1 vial
(S4) Prescription Only Medicine
Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: ,? Adjuvant treatment of stage III (Duke?s C) colon cancer after complete resection of ,the primary tumour ,? Treatment of advanced colorectal cancer
Visual Identification: Clear, colourless to slightly yellow solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2011-12-12